The Role of Interferon-α2 (IFN-α2) in the Treatment of Low-Grade Non-Hodgkin’s Lymphoma. Preliminary Results of a Randomized Study:IFN-α2 Plus Chlorambucil Versus Chlorambucil Alone
Interferon-α has been shown as an active agent in the treatment of hematological malignancies especially in hairy cell leukemia (HCL)  and low-grade non-Hodgkin’s lymphoma (NHL) .
KeywordsFollicular Lymphoma Hairy Cell Leukemia Maintenance Regimen Good Partial Remission Case Complete Remission
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 2.Quesada JR, Hersh EM, Manning JT, et al. (1986) Treatment of hairy cell leukemia with recombinant alpha interferon blood 68:493–497Google Scholar
- 3.Chisesi T, Capnist G, Vespignani M, Cetto G (1987) Interferon alpha 2b and chlorambucil in the treatment of non-Hodgkin’s lymphoma. Invest New Drugs 1:35–40Google Scholar
- 5.Gams R, Gordon D, Guaspari A, Turtle R (1984) Phase II trial of human polyclonal lymphoblastoid interferon (Wellcome) in the management of malignant lymphoma. J Clin Oncol 3:65Google Scholar
© Springer-Verlag, Berlin Heidelberg 1990